Thrombospondin^[*]

 

^* Aus dem Französischen übersetzt von R. Marx

• LITERATUR

• 1 Asch AS, Barnwell J, Silverstein RL, Nachman RL. Glycoprotein IV is the thrombospondin membrane receptor. Clin Res 1986; 34: 450 A (Abstr)
• 2 Asch AS, Leung LLK, Polley MJ, Nachman RL. Platelet membrane topography: colocalization of thrombospondin and fibrinogen with the glycoprotein Ilb-IIIa complex. Blood 1985; 66: 926-34.
• 3 Asch AS, Leung LLK, Shapiro J, Nachman RL. Human brain glial cells synthesize thrombospondin. Proc Natl Acad Sei USA 1986; 83: 2904-8.
• 4 Baenziger NL, Brodie GNT, Majerus PW. A thrombin-sensitive protein of human platelet membranes. Proc Natl Acad Sei USA 1971; 68: 240.
• 5 Bolin RB, Okumura T, Jamieson GA. Changes in distribution of platelet membrane glycoproteins in patients with myeloproliferative disorders. Am J Hematol 1977; 03: 63-71.
• 6 Booth WJ, Berndt WJ, Berndt MC, Castaldi PA. An altered platelet granule glycoprotein in patients with essential thrombocythaemia. J Clin Invest 1984; 73: 291-7.
• 7 Booth WJ, Castaldi P, Berndt M. Platelet thrombospondin hemagglutinin activity is due to aggregate formation. Thromb Res 1985; 39: 29-42.
• 8 Clemetson KJ, Capitano A, Pareti FL, McGregor JL, Liischer EF. Additional platelet membrane glycoprotein abnormalities in Glanzmann’s thrombasthenia: A comparison with normals by high resolution two-dimensional polyacrylamide gel electrophoresis. Thromb Res 1980; 18: 797-806.
• 9 Clezardin P, Dawes J. Structural and immunological comparison of thrombospondin from platelets and colostrum. Thromb Res. 1986 (Suppl VI) 55. (Abstr)
• 10 Clezardin P, Hunter NK, Lawler J, Pratt DA, McGregor JL, Pepper DS, Dawes J. Structural and immunological comparison of human thrombospondins isolated from platelets and from culture supernatants of endothelial cells and fibroblasts. Evidence for a thrombospondin polymorphism. Eur J Biochem 159: 569-79.
• 11 Clezardin P, Hunter NK, McGregor JL, Pepper DS, Dawes J. Structural and immunological differences between human platelet and endothelial thrombospondins. FEBS Lett 1986; 196: 49-53.
• 12 Clezardin P, McGregor JL, Dechavanne M, Clemetson KJ. Platelet membrane glycoprotein abnormalities in patients with myeloproliferative disorders and secondary thrombocytosis. Br J Haematol 1985; 60: 331-44.
• 13 Clezardin P, McGregor JL, Lyon M, Clemetson KJ, Huppert J. Characterization of two murine monoclonal antibodies (P10, P12) directed against different determinants of human blood patelet thrombospondin. Eur J Biochem 1986; 154: 95-102.
• 14 Coligan JE, Slayter HS. Structure of thrombospondin. J Biol Chem 1984; 259: 3944-8.
• 15 Danishefsky KJ, Alexander RJ, Detwiler TC. Formation of a stable complex of thrombin and the secreted platelet protein G (Thrombin-sensitive Protein, Thrombospondin) by thiol-disulfide exchange. Biochemistry 1984; 23: 4984-90.
• 16 Dawes J, Clemetson KJ, Gogstad GO, McGregor JL, Clezardin P, Prowse CV, Pepper DS. A radioimmunoassay for thrombospondin used in a comparative study of thrombospondin, beta-thromboglobu-lin and platelet factor 4 in healthy volunteers. Thromb Res 1983; 29: 569-81.
• 17 Dawes J, Miller WR, Brown K. Thrombospondin in milk and other breast secretions: a new marker for breast cyst classification. Thromb Haemost 1985; 54: 64 (Abstr)
• 18 Dixit VM, Galvin NJ, O’Rourke KM, Frazier WA. Monoclonal antibodies that recognize calcium-dependent structures of human thrombospondin. Characterization and mapping of their epitopes. J Biol Chem 261: 1962-8.
• 19 Dixit VM, Grant GA, Frazier WA, Santoro SA. Isolation of the fibrinogen-binding region of platelet thrombospondin. Biochem Biophys Res Comm 119: 1075-81.
• 20 Dixit VM, Grant GA, Santoro SA, Frazier WA. Isolation and characterization of a heparin-binding domain from the amino terminus of platelet thrombospondin. J Biol Chem 1984; 259: 10100-5.
• 21 Dixit VM, Haverstick DM, O’Rourke KM, Hennessy SW, Grant GA, Santoro SA, Frazier WA. A monoclonal antibody against human thrombospondin inhibits platelet aggregation. Proc Natl Acad Sei USA 1985; 82: 3472-6.
• 22 Dixit VM, Haverstick DM, O’Rourke KM, Hennessy SW, Grant GA, Santoro SA, Frazier WA. Effects of anti-thrombo-spondin monoclonal antibodies on the agglutination of erythrocytes and fixed, activated platelets by purified thrombospondin. Biochem 1985; 24: 4270-5.
• 23 Dixit VM, Hennessy SW, Grant GA, Rotwein P, Frazier WA. Characterization of a cDNA encoding the heparin and collagen binding domains of human thrombospondin. Proc Natl Acad Sei USA 1986; 83: 5449-53.
• 24 Eche N, Sie P, Caranobe C, Nouvel C, Pris J, Boneu B. Platelets in myeloproliferative disorders III. Glycoprotein profile in relation to platelet density. Scand J Haematol 1981; 26: 123-9.
• 25 French P, McGregor JL, Berruyer M, Belleville J, Touboul P, Dawes J, Dechavanne M. Comparative evaluation of plasma thrombospondin, beta-thromboglobulin and platelet factor 4 in acute myocardial infarction. Thromb Res 1985; 39: 619-24.
• 26 Galvin NJ, Dixit VM, O’Rourke KM, Santoro SA, Grant GA, Frazier WA. Mapping of epitopes for monoclonal antibodies against human platelet thrombospondin with electron microscopy and high sensitivity amino acid sequencing. J Cell Biol 1985; 101: 1434-41.
• 27 Gartner KT, Doyle MJ, Mosher DF. Effect of antithrombospondin antibodies on the hemagglutination activities of the endogenous platelet lectin and thrombospondin. Thromb Haemostas 1984; 52: 354-7.
• 28 Gartner KT, Gerrard JM, White JG, Williams DC. The endogenous lectin of human platelets is an alpha-granule component. Blood 1981; 58: 153-7.
• 29 Gartner KT, Gerrard JM, White JG, Williams DC. Fibrinogen is the receptor for the endogenous lectin of human platelets. Nature 1981; 289: 688-90.
• 30 Gartner KT, Walz DA, Alken M, Starr-Spires L, Olgivie ML. Antibodies against a 23 Kd heparin binding fragment of thrombospondin inhibit platelet aggregation. Biochem Biophys Res Comm 1984; 124: 290-5.
• 31 Gartner KT, Williams DC, Minion FC. Thrombin-induced platelet aggregation is mediated by a platelet membrane-bound lectin. Science 1978; 200: 1281-3.
• 32 Gartner KT, Williams DC, Phillips DR. Platelet plasma membrane lectin activity. Biochem Biophys Res Comm 1977; 79: 592-9.
• 33 George JN, Lyons RM, Morgan RK. Membrane changes associated with platelet activation. Exposure of actin on the platelet surface after thrombin-induced secretion. J Clin Invest 1980; 66: 1-9.
• 34 Gerrard JM, Phillips DR, Rao GHR, Plow EF, Walz DA, Ross R, Harker LA, White JG. Biochemical studies of two patients with the Gray Platelet Syndrome. Selective deficiency of platelet alpha-granules. J Clin Invest 1980; 66: 101-9.
• 35 Ginsburg AD. Platelet function in patients with high platelet counts. Ann Intern Med 1975; 82: 506-11.
• 36 Hardisty RM, Wolff HA. Haemorrhagic thrombocythaemia: a clinical and laboratory study. Brit J Haematol 1955; 01: 390-405.
• 37 Haupt H, Heimburger N. Humanserumproteine mit hoher Affinität zu Carboxyme-thylcellulose. Hoppe-Seyler’s Z Physiol Chem 1972; 353: 1125-32.
• 38 Hourdille P, Hasitz M, Belloc F, Nurden AT. Immunocytochemical study of the binding of fibrinogen and thrombospondin to ADP-and thrombin-stimulated human platelets. Blood 1985; 65: 912-20.
• 39 Hunter NR, Dawes J, McGregor IR, Pepper DS. Quantitation by radioimmunoassay of thrombospondin synthesised and secreted by human endothelial cells. Thromb Haemostas 1984; 52: 288-91.
• 40 Jaffe EA, Leung LLK, Nachman RL, Levin RI, Mosher DF. Thrombospondin is the endogenous lectin of human platelets. Nature 1982; 295: 246-8.
• 41 Jaffe EA, Ruggiero JT, Falcone DJ. Monocytes and Macrophages synthesize and secrete thrombospondin. Blood 1985; 65: 79-84.
• 42 Jaffe EA, Ruggiero JT, Leung LLK, Doyle MJ, McKeown-Longo PJ, Mosher DF. Cultured human fibroblasts synthesize and secrete thrombospondin and incorporate it into extracellular matrix. Proc Natl Acad Sei USA 1983; 80: 998-1002.
• 43 Kramer KH, Futh GM, Bensch KG, Karasek MA. Synthesis of extracellular matrix glycoproteins by cultured microvas-cular endothelial cells isolated from the dermis of neonatal and adult skin. J Cell Physiol 1985; 123: 1-9.
• 44 Lahav J, Lawler J, Gimbrone MA. Thrombospondin interactions with fibronectin and fibrinogen. Mutual inhibition in binding. Eur J Biochem 1984; 145: 151-6.
• 45 Lahav J, Scwartz MA, Hynes RO. Analysis of platelet adhesion with a radioactive chemical crosslinking reagent: interaction of thrombospondin with fibronectin and collagen. Cell 1982; 31: 253-62.
• 46 Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-5.
• 47 Lane DA, Ireland H, Wolff S, Ranasinghe E, Dawes J. Detection of enhanced in vivo platelet alpha granule release in different patient groups -comparison of beta-throm-boglobulin, platelet factor 4 and thrombospondin assays. Thromb Haemostas 1984; 52: 183-7.
• 48 Lawler J. Review: the structural and functional properties of thrombospondin. Blood 1986; 67: 1197-209.
• 49 Lawler JW, Chao FC, Cohen CM. Evidence for calcium-sensitive structure in platelet thrombospondin. Isolation and partial characterization of thrombospondin in the presence of calcium. J Biol Chem 1982; 257: 12257-65.
• 50 Lawler J, Cohen AM, Chao FC, Moriarty DJ. Thrombospondin in essential thrombo-cythemia. Blood 1986; 67: 555-8.
• 51 Lawler J, Derick LH, Connolly JE, Chen JH, Chao FC. The structure of human platelet thrombospondin. J Biol Chem 1985; 260: 3762-72.
• 52 Lawler J, Hynes RO. The structure of thrombospondin, an adhesive glycoprotein with multiple calcium-binding sites ancj homologies with several different proteins. J Cell Biol 1986; 103: 1635-48.
• 53 Lawler JW, Slayter HS. The release of heparin binding peptides from platelet thrombospondin by proteolytic action of thrombin, plasmin and trypsin. Thromb Res 1981; 22: 267-79.
• 54 Lawler JW, Slayter HS, Coligan JE. Isolation and characterization of a high molecular weight glycoprotein from human blood platelets. J Biol Chem 1978; 253: 8609-16.
• 55 Leung LLK. Role of thrombospondin in platelet aggregation. J Clin Invest 1986; 74: 1764-72.
• 56 Leung LLK, Harpel PC, Nachman RL Rabellino EM. Histidine-rich glycoprotein is present in human platelets and is released following thrombin stimulation. Blood 1983; 62: 1016-21.
• 57 Leung LLK, Nachman RL. Complex formation of platelet thrombospondin with fibrinogen. J Clin Invest 1982; 70: 542-9.
• 58 Leung LLK, Nachman RL, Harpel PC. Complex formation of platelet thrombospondin with histidine-rich glycoprotein. J Clin Invest 1984; 73: 5-12.
• 59 Lijnen HR, Hoylaerts M, Collen D. Isolation and characterization of a human plasma protein with affinity for the lysine binding sites in plasminogen. J Biol Chem 1982; 255: 10214-22.
• 60 Margossian SS, Lawler JW, Slayter HS. Physical characterization of platelet thrombospondin. J Biol Chem 1981; 256: 7495-500.
• 61 McKeown-Longo PJ, Hanning R, Mosher DF. Binding and degradation of platelet thrombospondin by cultured fibroblasts. J Cell Biol 1984; 98: 22-8.
• 62 McLaren KM. Immunohistochemical localisation of thrombospondin in human megakaryocytes and platelets. J Clin Pathol 1983; 36: 197-203.
• 63 McLure PD, Ingram GIC, Stacey RS, Glass UM, Matchett MO. Platelet function test in thrombocythemia and thrombocytosis. Brit J Haematol 1966; 12: 478-98.
• 64 McPherson J, Sage H, Bornstein P. Isolation and characterization of glycoprotein secreted by aortic endothelial cells in culture. Apparent identity with platelet thrombospondin. J Biol Chem 1981; 256: 11330-6.
• 65 Miller WR, Dawes J. Platelet-associated proteins in human breast cyst fluids. Clin Chim Acta 1985; 152: 37-42.
• 66 Mosher DF, Doyle MJ, Jaffe EA. Synthesis and secretion of thrombospondin by cultured human endothelial cells. J Biol Chem 1982; 93: 343-8.
• 67 Mumby SM, Abbott-Brown D, Raugi GJ, Bornstein P. Regulation of thrombospondin secretion by cells in culture. J Cellular Physiol 1984; 120: 280-8.
• 68 Mumby SM, Raugi GJ, Bornstein P. Interactions of thrombospondin with extracellular matrix proteins : selective binding to type V collagen. J Cell Biol 1984; 98: 646-52.
• 69 Nurden AT, Kunicki TJ, Dupuis D, Soria C, Caen JP. Specific protein and glycoprotein déficiences in platelets isolated from two patients with the Gray Platelet Syndrome. Blood 1982; 59: 709-18.
• 70 Phillips DR, Jennings LK, Prasanne H. Calcium-mediated association of glycoprotein G (thrombin-sensitive glycoprotein, thrombospondin) with human platelets. J Biol Chem 1980; 255: 11629-32.
• 71 Rabellino EM, Awidi A, Sitar G, Levene RB. Human marrow megakaryocytes synthesize platelet glycoproteins lib, Ilia and thrombospondin. Fed Proc 1985; 44: 1126 (Abstr)
• 72 Raccuglia G. Gray Platelet Syndrome: a variety of qualitative platelet disorder. Am J Med 1971; 51: 818-23.
• 73 Raugi GJ, Mumby SM, Abbott-Brown D, Bornstein P. Thrombospondin: synthesis and secretion by cells in culture. J Cell Biol 1981; 95: 351-4.
• 74 Raugi GJ, Mumby SM, Ready CA, Bornstein P. Location and partial characterization of the heparin-binding fragment of platelet thrombospondin. Thromb Res 1984; 36: 165-75.
• 75 Reinders JH, de Groot PG, Dawes J, Hunter NR, van Heugten HAA, Zandbergen J, Gonsalves MD, van Mourik JA. Comparison of secretion and subcellular localization of von Willebrand protein with that of thrombospondin and fibronectin in cultured human vascular endothelial cells. Biochim Biophys Acta 1985; 844: 306-13.
• 76 Roberts DD, Haverstick DM, Dixit VA, Frazier WA, Santoro SA, Ginsburg V. The platelet glycoprotein thrombospondin binds specifically to sulfated glycolipids. J Biol Chem 1985; 260: 9405-11.
• 77 Sage H, Bornstein P. Endothelial cells from umbilical vein and hemangioendothelioma secrete basement membrane largely to the exclusion of interstitial procollagens. Arteriosclerosis 1982; 02: 27-35.
• 78 Sage H, Farin FM, Striker GE, Fisher AB. Granular pneumocytes in primary culture secrete several major components of the extracellular matrix. Biochem 1983; 22: 2148-55.
• 79 Saglio SD, Slayter HS. Use of a radioimmunoassay to quantify thrombospondin. Blood 1982; 59: 162-6.
• 80 Silverstein RL, Leung LLK, Harpel PC, Nachman RL. Complex formation of platelet thrombospondin with plasminogen. Modulation of activation by tissue activator. J Clin Invest 1984; 74: 1625-33.
• 81 Silverstein RL, Leung LLK, Harpel PC, Nachman RL. Platelet thrombospondin forms a trimolecular complex with plasminogen and histidine-rich glycoprotein. J Clin Invest 1985; 75: 2065-73.
• 82 Spaet TH, Lejnieks I, Gaynor E, Goldstein M. Defective platelets in essential thrombo-cythemia. Arch Intern Med 1969; 124: 135-40.
• 83 Switalska HI, Niewiarowski S, Tuszynski GP, Rucinski B, Schmaier AH, Morinelli TA, Cierniewski C. Radioimmunoassay of human platelet thrombospondin: different patterns of thrombospondin and beta-thromboglobulin antigen. J Lab Clin Med 1985; 106: 690-700.
• 84 Takahashi K, Aiken M, Fenton IIJW, Wale DA. Thrombospondin fragmentation by alpha thrombin and resistance to gamma thrombin. Biochem J 1984; 224: 673-76.
• 85 Trzeciak MC, McGregor JL, Rénaux JL, Ville D, Berruyer M, Dawes J, Dechavanne M. Plasma thrombospondin in patients with chronic renal failure, liver disease and splenectomy. Thrombos Res 1985; 40: 121-8.
• 86 Tuszynski GP, Srivastava S, Switalska HI, Holt JC, Cierniewski CS, Niewiarowski S. The interaction of human platelet thrombospondin with fibrinogen. Thrombospondin purification and specificity of interaction. J Biol Chem 1985; 260: 12240-5.
• 87 Vischer P, Beeck H, Voss B. Synthesis, intracellular processing and secretion of thrombospondin in human endothelial cells. Eur J 1985; 153: 435-43.
• 88 Weber K, Osborn M. Proteins and sodium dodecyl sulphate: molecular weight determination on polyacrylamide gels and related procedures. In: Neurath H. (ed) The Proteins. vol. 1. Orlando: Academic Press; 1975: 179.
• 89 Wolff R, Plow EF, Ginsberg MH. Interaction of thrombospondin with resting and stimulated human platelets. J Biol Chem 1986; 261: 6840-6.